Senti Biosciences's total assets for Q2 2025 were $68.54M, a decrease of -17.20% from the previous quarter. SNTI total liabilities were $43.89M for the fiscal quarter, a -2.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.